GABA Immune Pathway Drives Female Brain Cancer Growth
Researchers identified a sex-specific immune mechanism where GABA signaling fuels glioblastoma progression in females. The process involves the reprogramming of myeloid-derived suppressor cells to help tumors evade the immune system. This discovery suggests a potential new target for immunotherapy.
What changed
New research identifies a female-specific GABA signaling pathway that promotes brain cancer growth via immune suppression.
Live updates
-
GABA Immune Pathway Drives Glioblastoma Growth in Females
confidence 90%Researchers identified a sex-specific immune mechanism where GABA signaling fuels glioblastoma progression in females. The process involves the reprogramming of myeloid-derived suppressor cells to help tumors evade the immune system. This discovery suggests a potential new target for immunotherapy.
What's confirmed:
- GABA signaling activation drives glioblastoma progression in female mice through myeloid-derived suppressor cells.
- GABA reprograms granulocytic myeloid-derived suppressor cells to fuel tumor growth solely in females.
- The GABA immune pathway helps glioblastoma evade immunity in females.
- Female glioblastoma patients exhibit higher GABA concentrations and richer GABA transcriptional signatures in immune cells compared to male patients.
Still unconfirmed:
- Blocking the female-only GABA signal may boost survival.
- GABA receptor B signaling enhances the inhibition of T cells by granulocytic myeloid-derived suppressor cells via the NOS2 pathway.
- The research was conducted by a team from the University of Miami.